DNMR — Danimer Scientific Income Statement
0.000.00%
Last trade - 00:00
- $88.57m
- $412.20m
- $46.68m
- 20
- 66
- 15
- 25
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | 10-K/A | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 47.3 | 58.7 | 53.2 | 46.7 |
Cost of Revenue | |||||
Gross Profit | — | 12.9 | 2.8 | -7.91 | -24.3 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 0.004 | 57.8 | 159 | 242 | 172 |
Operating Profit | -0.004 | -10.5 | -100 | -189 | -126 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.004 | -8.85 | -73.3 | -181 | -155 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.004 | -8.85 | -60.1 | -180 | -155 |
Net Income Before Extraordinary Items | |||||
Net Income | -0.004 | -8.85 | -60.1 | -180 | -155 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.004 | -8.85 | -60.1 | -180 | -155 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0 | -0.167 | -0.639 | -1.36 | -1.52 |